Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulforaphane in Children with Chronic Kidney Disease
NCT05653492Phase 2Active, not recruiting
- Sponsor
- University of Rochester
- Start
- May 2023
- Primary completion
- Apr 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulforaphane in chronic kidney disease (CKD), sponsored by University of Rochester. Started May 2023; status: active, not recruiting.
02
Drugs
sulforaphane
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05653492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05653492.